Diabetes is a complex condition influenced by both genetics and lifestyle factors. Early screening for genetic disease risk, coupled with adopting a healthy lifestyle tailored to one's individual circumstances, is crucial in preventing and slowing down dangerous complications.

With a shared goal of supporting the prevention, care, and management of diabetes, Genetica and DiaB signed a cooperation agreement on March 3, 2023. This partnership aims to provide the Diabetes community with the gene decoding service G-Diabetes, which assesses the risk of type 2 diabetes. With G-Diabetes, users can:

• Evaluate their hereditary diabetes risk.
• Understand the relationship between their genes and diabetes complications.
• Receive recommendations for lifestyle adjustments to effectively prevent and manage the disease.

In addition to the G-Diabetes package, Genetica and DiaB also offer gene decoding services that support the design of a healthy and comprehensive lifestyle, including:

• G-Stroke: Assessing the genetic risk of stroke.
• U-Nutri: Understanding the body's ability to metabolize chemicals.
• U-Vita: Providing the right amount of vitamins the body needs.

"There is a need for a supportive community dedicated to caring for people with diabetes. While many individuals have diabetes, each person has a unique medical history and distinct physical characteristics. Through our collaboration, Genetica and DiaB will deliver personalized solutions to patients, enabling them to effectively manage their disease and live happier, healthier lives," said Ms. Nguyen Thi Nhu Quynh, CEO of Genetica.

"I strongly believe that the combination of Genetica and DiaB, leveraging gene decoding technology and DiaB's Lifestyle Change program, supported by health experts, will help individuals with diabetes assess their disease risk, make necessary lifestyle adjustments, and better manage their condition," shared Mr. Tran Quoc Viet, Chief Technology Officer and Co-Founder of DiaB.

Over the past two decades, since scientists decoded the human genome, consisting of more than 20,000 genes and over 6 billion mutations, the evaluation of an individual's health has incorporated two factors: (1) Physical, mental, and social well-being, and (2) "Personalization" - genetic information. Recognizing that each body is unique and every genome is different, understanding one's genetic information empowers individuals to adapt their lifestyle and undertake appropriate healthcare measures.

About Genetica®

Genetica® is a gene decoding company headquartered in San Francisco, USA, and has been operating in Vietnam since 2018. Genetica®'s laboratory holds CLIA and CAP certifications, which are the highest standards for genetic testing laboratories in the United States. The report results are evaluated by scientific teams from renowned universities such as Harvard, Stanford, University of California San Francisco, and Cornell. Genetica collaborates with Illumina® and Thermo Fisher, two leading gene decoding organizations, to create a multi-gene decoding chip specifically designed for Asians, with Illumina recognizing its >99% accuracy and strict compliance with HIPAA security standards. All test samples and user genetic data are anonymized and encrypted.

Genetica provides four groups of gene decoding application services:

• Planning for raising and educating children.
• Personalized physical exercise and nutrition regimens.
• Assessing the risk of genetic diseases (stroke, allergies, viral infections).
• Screening for 20 common hereditary cancers in Asians.

In 2018, with support from the Vietnamese government, the Ministry of Planning and Investment, and incentive policies from the San Francisco office of the Ministry of Science and Technology and the Vietnam Innovation Network, Genetica decided to establish a regional office in Vietnam for expansion into Southeast Asia. Since then, Genetica has gained the trust of nearly 100,000 users in Asia.

In 2021, with sponsorship from the Ministry of Planning and Investment and the National Innovation Center (NIC), Genetica plans to build the largest gene decoding center in Southeast Asia, located in Vietnam, adhering to the highest international laboratory standards, including the CLIA and CAP standards.

About DiaB

DiaB is a company that provides programs to support people with diabetes in health care and daily lifestyle changes. With a team of Doctors, Experts, and Health Coaches, customers can apply knowledge and advice to improve issues in eating, exercising, and relaxing to stabilize blood sugar for a long time. long.

Constantly updating technology and applying modern medical knowledge for a healthier Diabetes community, DiaB operates with three core values:

• Empathy: DiaB believes that understanding customer needs and empathizing with customers during the collaboration process will bring optimal health outcomes to customers.
• Personalization: Each customer has different needs, life circumstances, and priorities. We focus on improving products towards personalization to better meet customer needs.
• Commitment: Our team follows standards of commitment to build trusting relationships with customers.